BÜHLMANN Quantum Blue® Infliximab

Quantum Blue® Adalimumab: Development of the first point of care rapid test for therapeutic drug monitoring of serum adalimumab levels

October 10, 2017
Quantum Blue® Infliximab Citation: F. I. Bantleon, S. Kräuchi, T. B. Schuster, M. Schneider, A. P. Abel Read Citation
Read more

The new infliximab point-of-care quantitative test can equally be used for therapeutic drug monitoring of biosimilars of infliximab

October 10, 2017
Quantum Blue® Infliximab Citation: J. Afonso, H.T. Sousa, I.Rosa, J.Carvalho, C. C. Dias, F. Magro on behalf GEDII Read Citation
Read more